Tue, Oct 21, 2014, 11:08 AM EDT - U.S. Markets close in 4 hrs 52 mins

Recent

% | $
Quotes you view appear here for quick access.

OncoSec Medical Incorporated Message Board

  • boaz.barilan boaz.barilan Dec 17, 2012 10:03 AM Flag

    Neopulse doesn't sell. Why Immunopulse will?

    There is no commercial activity with the approved Neopulse, so why assume Immunopulse will have a bright commercial future?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Boaz. Ok, we can tell you are new on ONCS and have not done enough DD. So let me break it down to you. Neopulse will sell and will do will on it's own, it is cleared for commercialization in the EU zone. A partner will be known soon. Mgm't just wants to do its due diligence in making sure it partners with the right firm that will support its growth moving forward. Look for this announcement Q1 2013 and this will be a $100Mil plus revenue maker by 2016 or sooner. While it doesn't have the glamour label and new technology that immunopulse has, it's option to marry and use different cancer approve drugs to treat large tumors can be a lifesaver for millions. Without a doubt immunotherapy is the new kid in the block ala CELSION has similar application but they use microwave technology to heat, ONCS once it takes hold with immunopulse and partner announced will skyrocket as well. JMO.

      Sentiment: Strong Buy

    • If I had head or neck cancer I would be knocking their door down! Have fun with your surgery.

      Sentiment: Strong Buy

 
ONCS
0.4601-0.0049(-1.05%)10:48 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.